<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28076626</article-id><article-id pub-id-type="pmc">5407138</article-id><article-id pub-id-type="doi">10.5935/1678-9741.20160092</article-id><article-categories><subj-group subj-group-type="heading"><subject>Brief Communication</subject></subj-group></article-categories><title-group><article-title>Development of a Multifunctional Needle for Percutaneous Heart Biopsy
and Cell Therapy. A Technical Note</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Soubihe</surname><given-names>Nathan Valle</given-names><suffix>Junior</suffix></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Albuquerque</surname><given-names>Agnes Afrodite S.</given-names></name><degrees>BsC</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Arc&#x000ea;ncio</surname><given-names>Livia</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Thomazini</surname><given-names>Jos&#x000e9; Antonio</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Schmidt</surname><given-names>Andre</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Evora</surname><given-names>Paulo Roberto B.</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label> Department of Surgery and Anatomy, Faculdade de Medicina
de Ribeir&#x000e3;o Preto da Universidade de S&#x000e3;o Paulo (FMRP-USP),
Ribeir&#x000e3;o Preto, SP, Brazil.</aff><aff id="aff2"><label>2</label> Department of Internal Medicine, Faculdade de Medicina
de Ribeirao Preto da Universidade de S&#x000e3;o Paulo (FMRP-USP), Ribeir&#x000e3;o
Preto, SP, Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: Paulo Roberto Barbosa Evora, Faculdade de
Medicina de Ribeir&#x000e3;o Preto da Universidade de S&#x000e3;o Paulo
Departamento de Cirurgia e Anatomia, Av. Bandeirantes, 3900, Ribeir&#x000e3;o
Preto, SP, Brazil - Zip code: 14048-900. E-mail:
<email>prbevora@fmrp.usp.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Nov-Dec</season><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Nov-Dec</season><year>2016</year></pub-date><volume>31</volume><issue>6</issue><fpage>465</fpage><lpage>467</lpage><history><date date-type="received"><day>11</day><month>8</month><year>2016</year></date><date date-type="accepted"><day>05</day><month>11</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><p>Validation of transendocardial injection as a method for delivering therapeutic
agents to the diseased heart is increasing. Puncture heart biopsies should
re-emerge as a possible alternative method to allow access to the myocardium and
implantable biomaterial for cell therapy. Therefore, this work aims to present a
percutaneous puncture device for biopsy and intramyocardial biomaterial
injection, standardize the technique and attest to the safety of the method. The
adaptation consists of creating myocardial microlesions that allow for better
fixation of stem cells. The objective of this technical note covers only the
development of the needle and the histological quality of the biopsies. It has
not been used in humans yet.</p></abstract><kwd-group><kwd>Stem Cells</kwd><kwd>Biopsy</kwd><kwd>Myocardium</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>The search for safe and effective methods of obtaining intact infarction fragments
has inspired countless authors and has been the subject of several studies. Over the
years, the development of different procedures that allow the obtaining of cardiac
tissue fragments went through several stages, evolving from open myocardiectomy and
procedures with puncture needles to endovascular catheters. Despite being in disuse
today, procedures with puncture needles are particularly important for offering
access to the myocardium and the left ventricular cavity. Thus, puncture heart
biopsies should re-emerge as a possible alternative method to allow access to the
myocardium and implantable biomaterial for cell therapy. Therefore, this work aims
to present a puncture device for biopsy and intramyocardial biomaterial injection,
standardize the technique and attest to the safety of the method. The adaptation
consists of creating myocardial microlesions that allow for better fixation of stem
cells.</p><p>The objective of this study covers only the development of the needle and the
histological quality of the biopsies. A previous note was published in this
journal<sup>[</sup><sup><xref rid="r1" ref-type="bibr">1</xref></sup><sup>]</sup>.</p></sec><sec><title>DESCRIPTION OF TECHNOLOGY</title><p>The instrument for puncturing and injecting biological material is composed of an
external needle (1), called coupling infusion, which contains a blunt tip (2) and
multiple 0.5 mm diameter holes (3) at its end. Internally, it is fitted with a blunt
mandrel that can be mobilized to fill the lateral holes, occluding or releasing
them. The procedure for producing microlesions is done by replacing the blunt
mandrel with a brush-mandrel (4), structurally designed to fill the holes by
exteriorizing the small bristles (5) (<xref ref-type="fig" rid="f1">Figure
1</xref>). The instrument is equipped with a locking mechanism that allows its
complete mobilization as one single unit for microlesions. It can also be used
simply as an external needle, thus becoming an instrument for biological injection.
It was designed with an optional feather-mandrel (<xref ref-type="fig" rid="f2">Figure 2</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Instrument Design. <bold>A -</bold> External needle; <bold>B -</bold>
Lateral holes for infusion; <bold>C -</bold> Blunt tip punch + brush
mandrel; <bold>D -</bold> Internal mandrel.</p></caption><graphic xlink:href="rbccv-31-06-0465-g01"/></fig>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Instrument Design. Flexible metallic bristles (&#x0201c;Feather mandrel&#x0201d; as an
option to the brush mandrel).</p></caption><graphic xlink:href="rbccv-31-06-0465-g02"/></fig>
</p><p>The percutaneous needle is introduced at a point 1 to 2 cm away from the apex of the
heart (<xref ref-type="fig" rid="f3">Figure 3A</xref>) and it reaches the left
ventricular cavity (<xref ref-type="fig" rid="f3">Figure 3B</xref>). A slight and
slow retreat of the needle until the blood jetting stops means that the muscular
wall of the left ventricular myocardium completely occluded the holes (<xref ref-type="fig" rid="f3">Figure 3C</xref>). It is noteworthy that the
distribution of these holes on the side of the needle never exceeds the minimum
width of the common ventricular wall, allowing a slow and accurate withdrawal
movement of the needle. Blocking the blood flow through the proximal opening without
the mandrel is an accurate indication of the perfect location of the side holes in
the ventricular wall. Then, the operator can introduce the mandrel with bristles for
scraping so as to cause microlesions (<xref ref-type="fig" rid="f3">Figure
3D</xref>). After withdrawing the brush mandrel, the syringe containing biological
material to be infused into the previously scarified myocardium can be engaged. The
instrument is easily visualized by either echocardiography (<xref ref-type="fig" rid="f4">Figure 4A</xref>) or radioscopy (<xref ref-type="fig" rid="f4">Figure
4B</xref>).</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Percutaneous puncture technique. <bold>A -</bold> The percutaneous needle
is introduced at a point 1 to 2 cm away from the apex of the heart;
<bold>B -</bold> it reaches the left ventricular cavity (pulsed
blood jetting); <bold>C -</bold> A slight and slow retreat of the needle
until the blood jetting stops means that the muscular wall of the left
ventricular myocardium completely occluded the holes; and <bold>D
-</bold> The operator introduces the mandrel with bristles for
scraping so as to create microlesions. After withdrawing the brush
mandrel, the syringe containing the biological material to be infused
into the previously scarified myocardium can be engaged.</p></caption><graphic xlink:href="rbccv-31-06-0465-g03"/></fig>
<fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>The instrument is easily visualized. <bold>A &#x02013;</bold> Echocardiography;
<bold>B &#x02013;</bold> Radioscopy.</p></caption><graphic xlink:href="rbccv-31-06-0465-g04"/></fig>
</p><p>The technique has been tested in <italic>in vivo</italic> pig models and it has shown
itself to be feasible and safe. The results are presented through microscopic
aspects of the heart (Hematoxylin-eosin, Masson, and Evans blue) (<xref ref-type="fig" rid="f5">Figure 5</xref>).</p><p>
<fig id="f5" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Histological samples. The results are presented through microscopic
aspects of the heart. <bold>A</bold> and <bold>B -</bold>
Hematoxylin-eosin; <bold>C -</bold> Masson; and <bold>D -</bold> Evans
blue.</p></caption><graphic xlink:href="rbccv-31-06-0465-g05"/></fig>
</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The initial motivation for this work was the proposed experimental procedure for
injection of stem cells in the myocardium of animals and humans through a
multifunctional transthoracic puncture needle. The design followed two classical
principles: 1) safety, in order to avoid accidents; and 2) technical capability of
reaching the wall of the heart muscle, ensuring the biomaterial was left there, and
preventing its release into the ventricular cavity or between the epicardial and
pericardial. This procedure tends to become an intervention with increased accuracy
and increased safety due to multiple punctures and a greater extent of myocardial
tissue covered with cell therapy. In addition, direct injection as adjunctive
therapy to revascularization surgery is a viable proposition, but it caters to a
select group of patients referred to surgical revascularization immediately after an
acute ischemic event. Intramyocardial injection during thoracotomy, in the surgical
treatment of coronary artery disease, is a real possibility<sup>[</sup><sup><xref rid="r2" ref-type="bibr">2</xref></sup><sup>-</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>]</sup>.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>In conclusion, the new instrument is designed to be a multifunctional central
feature: 1) It allows the operator to access the left ventricular cavity through the
transthoracic without risk of injury (perforation) of the coronary arteries; 2) It
allows for myocardial laceration of the muscle fibers by severing them and ripping
the myocardium, thereby generating muscle microlesions through its arbor with
bristles and promoting an "inflammation beneficial to the cell transplant process";
3) The need for multiple punctures in the heart muscle to infuse standard biological
material while performing cell therapy made us aware that the percutaneous needle
could generate greater technical difficulty, so we propose that it be used with the
surgical technique of video thoracotomy; and 4) The device should be used for
intraoperative stem cell injections, but it has not been used in humans yet.</p><table-wrap id="t" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup width="50%" span="1"><col span="1"/><col span="1"/></colgroup><thead><tr><th colspan="2" align="left" rowspan="1"><bold>Authors' roles &#x00026;
responsibilities</bold></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">NVSJ</td><td align="left" rowspan="1" colspan="1">Original idea and design of the project; final
manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">AASA</td><td align="left" rowspan="1" colspan="1">Technical support; final manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">LA</td><td align="left" rowspan="1" colspan="1">Writing and formatting of the text; final manuscript
approval</td></tr><tr><td align="left" rowspan="1" colspan="1">JAT</td><td align="left" rowspan="1" colspan="1">Histological study; final manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">AS</td><td align="left" rowspan="1" colspan="1">Project planning; final manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">PRBE</td><td align="left" rowspan="1" colspan="1">Study design and writing of the paper; final manuscript
approval</td></tr></tbody></table></table-wrap></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>Dr. Jos&#x000e9; Eduardo Krieger and Dr. Rafael Dariolli, for their support and
guidance during preliminary needle testing in INCOR-SP. Antonio Renato Meirelles e
Silva, for his contribution to the histological study. Dr. Fabio Jatene, for the
suggestions during the Master's Thesis public presentation.</p></ack><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at the Laboratory of Endothelium and Cardiovascular
Function, Department of Surgery and Anatomy, Faculdade de Medicina de
Ribeir&#x000e3;o Preto da Universidade de S&#x000e3;o Paulo (FMRP-USP), as a
Master's degree thesis, Ribeir&#x000e3;o Preto, SP, Brazil.</p></fn><fn fn-type="supported-by"><p>Financial support: Conselho Nacional de Pesquisa (CNPq) and
Funda&#x000e7;&#x000e3;o de Apoio ao Ensino, Pesquisa e Assist&#x000ea;ncia do
Hospital das Cl&#x000ed;nicas da Faculdade de Medicina de Ribeir&#x000e3;o Preto
da Universidade de S&#x000e3;o Paulo (FAEPA/HCFMRP/USP).</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soubihe</surname><given-names>NV</given-names><suffix>Junior</suffix></name><name><surname>Schmidt</surname><given-names>A</given-names></name><name><surname>Albuquerque</surname><given-names>AA</given-names></name><name><surname>Evora</surname><given-names>PR</given-names></name></person-group><article-title>Presentation of a needle for direct or percutaneous myocardium
stem cells injection</article-title><source>Rev Bras Cir Cardiovasc</source><year>2013</year><volume>28</volume><issue>3</issue><fpage>405</fpage><lpage>407</lpage><pub-id pub-id-type="pmid">24343692</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krause</surname><given-names>K</given-names></name><name><surname>Jaquet</surname><given-names>K</given-names></name><name><surname>Schneider</surname><given-names>C</given-names></name><name><surname>Haupt</surname><given-names>S</given-names></name><name><surname>Lioznov</surname><given-names>MV</given-names></name><name><surname>Otte</surname><given-names>KM</given-names></name><etal/></person-group><article-title>Percutaneous intramyocardial stem cell injection in patients with
acute myocardial infarction: first-in-man study</article-title><source>Heart</source><year>2009</year><volume>95</volume><issue>14</issue><fpage>1145</fpage><lpage>1152</lpage><pub-id pub-id-type="pmid">19336430</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ladage</surname><given-names>D</given-names></name><name><surname>Ishikawa</surname><given-names>K</given-names></name><name><surname>Tilemann</surname><given-names>L</given-names></name><name><surname>M&#x000fc;ller-Ehmsen</surname><given-names>J</given-names></name><name><surname>Kawase</surname><given-names>Y</given-names></name></person-group><article-title>Percutaneous methods of vector delivery in preclinical
models</article-title><source>Gene Ther</source><year>2012</year><volume>19</volume><issue>6</issue><fpage>637</fpage><lpage>641</lpage><pub-id pub-id-type="pmid">22418064</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galantier</surname><given-names>M</given-names></name><name><surname>Moreira</surname><given-names>GB</given-names></name><name><surname>Bub</surname><given-names>RF</given-names></name><name><surname>Galantier</surname><given-names>J</given-names></name><name><surname>Buffolo</surname><given-names>E</given-names></name><name><surname>Carvalho</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Revasculariza&#x000e7;&#x000e3;o transmioc&#x000e1;rdica a
laser</article-title><source>Rev Bras Cir Cardiovasc</source><year>1996</year><volume>11</volume><issue>2</issue><fpage>67</fpage><lpage>74</lpage></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dallan</surname><given-names>LA</given-names></name><name><surname>Gowdak</surname><given-names>LH</given-names></name><name><surname>Lisboa</surname><given-names>LA</given-names></name><name><surname>Schettert</surname><given-names>I</given-names></name><name><surname>Krieger</surname><given-names>JE</given-names></name><name><surname>Cesar</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Cell therapy plus transmyocardial laser revascularization: a
proposed alternative procedure for refractory angina</article-title><source>Rev Bras Cir Cardiovasc</source><year>2008</year><volume>23</volume><issue>1</issue><fpage>46</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">18719828</pub-id></element-citation></ref></ref-list></back></article>